ArticleMolecular therapy. Oncology2025

Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model.

Chuyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.